Report
Debbie Wang
EUR 100.00 For Business Accounts Only

ConvaTec Is Moving in the Right Direction; No Change to Our FVE

ConvaTec’s abbreviated first-quarter results demonstrated improvement, and we’re leaving our fair value estimate unchanged as the firm remains on track to meet our full-year projections. Despite a string of operational setbacks in 2017, we think ConvaTec is moving in the right direction as it builds on robust demand for its Aquacel wound-care products, greater presence in U.S. home distribution, and the introduction of the MiniMed Mio Advanced infusion set inserter. We are confident that ConvaTe...
Underlying
ConvaTec Group Plc

ConvaTec Group is a holding company. Through its subsidiaries, Co. is a global medical products and technologies group. Co. has four franchises: Advanced Wound Care, which provides wound dressings, devices and skin care products used for the management of acute and chronic wounds; Ostomy Care, which focuses on devices, accessories and services for individuals who have a stoma; Continence and Critical Care, which provides products for people with urinary continence issues; and Infusion Devices, which develops and manufactures disposable infusion sets for the suppliers of insulin pumps for diabetes treatment and similar pumps used in continuous infusion treatments for other conditions.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch